openPR Logo
Press release

The oral proteins and peptides market is anticipated to grow at a CAGR of 20%, during 2022-2032, claims Roots Analysis

06-15-2022 01:15 PM CET | Health & Medicine

Press release from: Roots Analysis

Oral Proteins and Peptides Market - Context

Oral Proteins and Peptides Market - Context

Roots Analysis has announced the addition of "Oral Proteins and Peptides Market, 2022-2032" report to its list of offerings.

Over the past few years, technological advancements in delivery formulations have enabled the adoption of the oral route of administration in lieu of the widely adopted subcutaneous route. Since the approval of the first oral protein / peptide in 2012, there has been an increase in the demand for this class of therapeutics, owing to their ability to treat a myriad of disease indications. Further, considering the ease of administration, increased treatment adherence and reduced risk of non-compliance associated with this delivery approach, the domain is anticipated to gain significant traction in the foreseen future.

To order this 465+ page report, which features 169+ figures and 207 + tables, please visit

Key Market Insights

-More than 130 oral proteins / peptides are currently under development
Over 60% of the therapies in this domain are based on peptide molecules. It is worth mentioning that most of the drug candidates are being developed for the treatment of metabolic disorders. Further, majority of these therapies (58%) are based on receptor stimulation mechanism.

~52 companies claim to be engaged in the development of oral proteins / peptides, globally
Since 2006, 22 companies have been established in this market. Further, around 57% of the industry stakeholders are small companies. In addition, majority (65%) of the oral proteins / peptide developers are based in North America, primarily in the US.

-Close to 320 patents have been filed / granted for oral proteins / peptides, since 2016
Owing to the rising research efforts of several industry and non-industry players engaged in this domain, close to 70% of patent applications have been filed post 2018. It is worth noting that, around 75% of the patents were filed / granted in the US. This was followed by European Patent Office (24.7%).

-Partnership activity has increased at an annualized rate of over 44% in this domain, during 2018-2021
Maximum number of partnerships were inked in 2021, indicating an increase in the activity in this domain. Majority of these agreements were reported to be licensing agreements, representing over 30% of the total number of instances.

-USD 2.5+ billion has been invested by both private and public investors, since 2017
The maximum funding amount was raised through debt financing (36%), secondary offerings (27%) and venture capital (13%) funding. Further, around 92% of the funding instances were reported by players based in the US.

-235+ clinical trials evaluating oral proteins / peptides have been registered, worldwide
The clinical research activity (in terms of number of trials registered) related to oral proteins and peptides increased at a CAGR of 28%, during the period 2016-2021. Of the total number of trials, 77% have already been completed, while 23% studies are presently active.

-North America is anticipated to capture over 80% of the global market share in 2032
Around 44% of the market revenues are expected to be generated from sales of therapeutics intended for the treatment of type II diabetes, in 2032. Further, therapies based on the receptor stimulation mechanism are expected to occupy a larger share (62%) of the overall market in 2032.

To request a sample copy / brochure of this report, please visit

Key Questions Answered

-Who are the key players engaged in the development of oral protein / peptide therapeutics?
-Which technologies are leveraged the most by oral protein / peptide therapy developers?
-Who are the key opinion leaders in this domain?
-Which geographies are the most active in conducting clinical trials focused on oral protein / peptide therapeutics?
-Which companies have received the maximum funding for the development for oral protein / peptide therapeutics? Who are the most prominent investors?
-Which partnership models are commonly adopted by industry stakeholders for the development of oral protein / peptide therapeutics?
-Which organizations have filed the maximum number of patents in this field?
-How is the current and future market opportunity likely to be distributed across key market segments?
-The financial opportunity within the oral proteins / peptides market has been analyzed across the following segments:

-Target Disease Indication
Celiac Disease
Chronic Idiopathic Constipation
Enteric Hyperoxaluria
Inflammatory Bowel Disease
Type II Diabetes

-Type of Molecule

-Biological Target
Insulin receptor

-Mechanism of Action
Receptor stimulation
Substrate degradation

-Key Players
Ironwood Pharmaceuticals
Salix Pharmaceuticals
Allena Pharmaceuticals
Innovate Biopharmaceuticals
Diasome Pharmaceuticals
Oramed Pharmaceuticals
Key Geographical Regions

North America
Asia-Pacific and the Rest of the World

The report features inputs from eminent industry stakeholders, according to whom, the oral proteins / peptides market is primarily driven by the increasing demand for such molecules. The report includes detailed transcripts of discussions held with the following experts:

-Dinesh Srinivasan (Director, Anthera Pharmaceuticals)
-Stig K Hansen (Co-founder and CEO, Carmot Therapeutics)
-Terry Dyck (CEO, IGY Life Sciences and Technology)
-Richard Franklin (CEO, Constant Therapeutics)

The research includes detailed profiles of drugs being developed by key players (listed below); each profile features an overview of the drug and technology used, current development status, and recent clinical trial results.

-Allena Pharmaceuticals
-Diasome Pharmaceuticals
-Innovate Biopharmaceuticals
-Ironwood Pharmaceuticals
-Oramed Pharmaceuticals
-Salix Pharmaceuticals

For additional details, please visit or email

Contact Details
Gaurav Chaudhary

Roots Analysis
A430, 4th Floor,
Bestech Business Towers, Sector 66, Mohali, India
+1 (415) 800 3415
+44 (122) 391 1091

We specialise in analysing areas which have lacked quality research so far or require more focussed understanding within the broader industry. All our reports are structured in a way to enable the reader develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we also provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release The oral proteins and peptides market is anticipated to grow at a CAGR of 20%, during 2022-2032, claims Roots Analysis here

News-ID: 2653595 • Views: 350

More Releases from Roots Analysis

The gene therapy market is projected to be worth USD 17.3 billion in 2035, growi …
Given the potential of gene therapies to permanently cure a diverse array of clinical conditions at the genetic level, the current pipeline is rapidly growing; a number of such therapies are currently being evaluated in late stages of development London Roots Analysis has announced the addition of "Gene Therapy Market" report to its list of offerings. Post the emergence of blockbuster gene therapies, such as ZOLGENSMA® (for spinal muscular atrophy type
The companion diagnostics development services market, is anticipated to grow at …
Roots Analysis has announced the addition of "Companion Diagnostics Development Services Market (2nd Edition), 2022-2035" report to its list of offerings. The growing pipeline of patient-centric targeted therapies has led to a surge in demand for companion diagnostics; these tests are known to improve the success rates of late-stage trials by almost three-fold. The development and approval of these FDA classified high-risk devices requires multidisciplinary expertise and an established network of
The viral vaccine cell culture media market is projected to grow at a CAGR of 5. …
Roots Analysis has announced the addition of the "Viral Vaccine Cell Culture Media Market, 2022-2035" report to its list of offerings. Vaccine production is a highly regulated and challenging process; specifically, the production of viral components or whole viruses further adds to the complexity. Additionally, it is paramount for vaccine cultures to be devoid of any contamination and be highly effective. In order to mitigate the aforementioned challenges, pharma and
The continuous manufacturing market is projected to grow at an annualized rate o …
Roots Analysis has announced the addition of "Continuous Manufacturing Market - Small Molecules and Biologics (2nd Edition), 2022-2035" ( report to its list of offerings. The outbreak COVID-19 pandemic had disruptive impact on the overall pharmaceutical supply chain, due to the absence of workers at manufacturing sites and distribution networks' restrictions. Continuous manufacturing offers a practicable solution as the continuous processes are automated on a larger scale, and the FDA and

All 5 Releases

More Releases for Pharmaceuticals

Opioid Use Disorder Market ||Indivior, Alkermes, Titan Pharmaceuticals, Hikma Ph …
Zion Market Research published a new 110+ pages industry research “Opioid Use Disorder Market by Drug (Buprenorphine, Methadone and Naltrexone) – Global Industry Perspective Comprehensive Analysis and Forecast, 2019-2025” is exhaustively researched and analyzed in the report to help market players to improve their business tactics and ensure long-term success. The authors of the report have used easy-to-understand language and uncomplicated statistical images but provided thorough information and detailed data
Global Halal Pharmaceuticals Market 2019 - CCM Pharmaceuticals, Pharmaniaga, Ros …
This new report by Eon Market Research, titled “Global Halal Pharmaceuticals Market 2019 Research Report, 2015 – 2025” offers a comprehensive analysis of Halal Pharmaceuticals industry at a global as well as regional and country level. Key facts analyzed in this report include the Halal Pharmaceuticals market size by players, regions, product types and end industries, history data 2014-2018 and forecast data 2019-2025. This report primarily focuses on the study
Topical Antibiotic Pharmaceuticals Market 2016-2026 | Teva Pharmaceuticals, Perr …
Topical antibiotics are applied to a certain area of the skin to kill infections. Application of topical antibiotics has a number of advantages upon comparison of systemic delivery in the treatment of skin infections. Skin and soft tissue infections (SSTIs) involve microbial invasion of the skin and underlying soft tissues infections are one of the most commonly occurring conditions amongst people. Most of these infections are minor and chronic in
Lipid Disorder Treatment Market to 2017 - 2026: Teva Pharmaceuticals, Mylan Phar …
Researchmoz added Most up-to-date research on "Lipid Disorder Treatment Market - Global Industry Analysis, Share, Size, Growth, Trends and Forecast 2017 - 2026" to its huge collection of research reports Extensive research report on global lipid disorders treatment market skilfully crafted by Transparency Market Research depicts the current as well as future scenario of various drugs used to treat lipid disorders. The research study includes analysis on key developments that are
Halal Pharmaceuticals 2018 Global Market Key Players -CCM Pharmaceuticals, Pharm …
Halal Pharmaceuticals Market 2018 Wiseguyreports.Com Adds “Halal Pharmaceuticals – Global Market Demand, Growth, Opportunities, Manufacturers, Analysis of Top Key Players and Forecast to 2025” To Its Research Database. Description:  In this report, the global Halal Pharmaceuticals market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report is segmented into several key Regions,
Global Wilson's Disease Market 2017- Valeant Pharmaceuticals International, Meda …
The Global Wilson's Disease Market 2017 Research Report includes a complete and meticulous study of Wilson's Disease industry covering different aspects like market volume, market Share, market strategies, Wilson's Disease growth trends, variety of applications, utilization volume, demand and supply analysis, production capacity and Wilson's Disease industry cost structures during Forecast period from 2017 to 2022. The report titled Global Wilson's Disease Market 2017 provides the comprehensive study of Wilson's Disease